Bumetanide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
Conditions:   Epilepsy;   Alzheimer Disease;   Epilepsy Intractable Intervention:   Drug: NPT 2042 (bumetanide analog) or Matching Placebo Sponsor:   NeuroPro Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2022 Category: Research Source Type: clinical trials

Diuretics and Volume Overload in Early CKD
Conditions:   Chronic Kidney Disease;   Hypertension Intervention:   Drug: Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide) Sponsor:   VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials